![Mercè Mengual](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Mercè Mengual
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Sanofi España SA
1
| Subsidiary | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mercè Mengual
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President | |
MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Portal Instruments, Inc.
![]() Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
Prolifaron, Inc.
![]() Prolifaron, Inc. Medical SpecialtiesHealth Technology Part of AstraZeneca PLC, Prolifaron, Inc. is a company that develops antibodies addressing multiple disease areas. The company is based in San Diego, CA. The company was founded by John Randolph Larson, Carlos F. Barbas. Prolifaron was acquired by Alexion Pharmaceuticals, Inc., part of AstraZeneca PLC from July 21, 2021 on September 25, 2000 for $41 million. | Medical Specialties | Chief Executive Officer | |
The College of William & Mary | College/University | Undergraduate Degree | |
Bird Rock Bio, Inc.
![]() Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Chief Executive Officer | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member | |
Alexion Antibody Technologies
![]() Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Miscellaneous Commercial Services | President | |
Thermalin, Inc.
![]() Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Director/Board Member | |
Warp Drive Bio, Inc.
![]() Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
Sanofi-Sunrise
![]() Sanofi-Sunrise Investment ManagersFinance Sanofi-sunrise is a venture capital subsidiary of Sanofi-Aventis Groupe SA founded in 1900. The firm is headquartered in Cambridge, Massachusetts . | Investment Managers | Private Equity Investor | |
PIC Therapeutics, Inc.
![]() PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 14 |
Frankreich | 2 |
Sektoral
Health Technology | 10 |
Consumer Services | 3 |
Commercial Services | 3 |
Finance | 2 |
Operativ
Director/Board Member | 7 |
President | 5 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Katherine Bowdish | 15 |
- Börse
- Insiders
- Mercè Mengual
- Unternehmensverbindungen